Optimisation of circulating cell-free DNA (cfDNA) purification for KRAS mutation and HPV detection in cancer patients

被引：0
|
作者：
Mazurek, A. M.
Fiszer-Kierzkowska, A.
Scieglinska, D.
Wozniak, G.
Kawczynski, R.
Glowacki, G.
Rutkowski, T.
Malusecka, E.
机构：
来源：
FEBS JOURNAL | 2013年 / 280卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [11] Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer
    Kuo, Yung-Bin
    Chen, Jinn-Shiun
    Fan, Chung-Wei
    Li, Yi-Shuan
    Chan, Err-Cheng
    CLINICA CHIMICA ACTA, 2014, 433 : 284 - 289
  • [12] Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
    Mouliere, Florent
    El Messaoudi, Safia
    Gongora, Celine
    Guedj, Anne-Sophie
    Robert, Bruno
    Del Rio, Maguy
    Molina, Franck
    Lamy, Pierre-Jean
    Lopez-Crapez, Evelyne
    Mathonnet, Muriel
    Ychou, Marc
    Pezet, Denis
    Thierry, Alain R.
    TRANSLATIONAL ONCOLOGY, 2013, 6 (03): : 319 - U281
  • [13] Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab
    Marzia Del Re
    Paola Ulivi
    Alessandro Passardi
    Wainer Zoli
    Romano Danesi
    Dino Amadori
    EPMA Journal, 2014, 5 (Suppl 1):
  • [14] KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients
    Garzon, Monica
    Villatoro, Sergi
    Teixido, Cristina
    Mayo, Clara
    Martinez, Alejandro
    Llanos Gil, Maria de Los
    Viteri, Santiago
    Morales-Espinosa, Daniela
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (05) : 511 - 516
  • [15] KRAS Mutation Analysis Using Cell-free DNA of Pancreatic Cancer
    Takase, Yorihiko
    Naito, Yoshiki
    Kawahara, Akihiko
    Okabe, Yoshinobu
    Sadashima, Eiji
    Abe, Hideyuki
    Akiba, Jun
    ANTICANCER RESEARCH, 2023, 43 (06) : 2683 - 2690
  • [16] KRAS mutant circulating free DNA (cfDNA) and circulating tumor cell (CTC) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
    Earl, J.
    Garcia-Nieto, S.
    Martinez-Avila, C.
    Montans, J.
    Sanjuanbenito, A.
    Rodriguez-Garrote, M.
    Lisa, E.
    Mendia, E.
    Lobo, E.
    Malats, N.
    Carrato, A.
    Guillen, C.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S87 - S87
  • [17] Circulating cell-free DNA for cancer early detection
    Gao, Qiang
    Zeng, Qiang
    Wang, Zhijie
    Li, Chengcheng
    Xu, Yu
    Cui, Peng
    Zhu, Xin
    Lu, Huafei
    Wang, Guoqiang
    Cai, Shangli
    Wang, Jie
    Fan, Jia
    INNOVATION, 2022, 3 (04):
  • [18] Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) study
    Liu, M. C.
    Klein, E.
    Hubbell, E.
    Maddala, T.
    Aravanis, A. M.
    Beausang, J. F.
    Filippova, D.
    Gross, S.
    Jamshidi, A.
    Kurtzman, K.
    Shen, L.
    Zhang, N.
    Venn, O.
    Yecies, J.
    Patel, S.
    Smith, D. A.
    Yeatman, T.
    Seiden, M.
    Hartman, A-R.
    Oxnard, G.
    ANNALS OF ONCOLOGY, 2018, 29 : 14 - 14
  • [19] Association between Kras mutation in circulating cell-free tumor DNA and clinical progression of colorectal cancer in patients receiving cetuximab
    Del Re, M.
    Ulivi, P.
    Belcari, F.
    Passardi, A.
    Zoli, W.
    Amadori, D.
    Danesi, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S31 - S31
  • [20] Circulating cell-free tumor DNA (cfDNA) testing in small cell lung cancer.
    Morgensztern, Daniel
    Devarakonda, Siddhartha H. K.
    Masood, Ashiq
    Waqar, Saiama Naheed
    Carmack, Alicia C.
    Banks, Kimberly C.
    Lanman, Richard Burnham
    Govindan, Ramaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345